<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03522025</url>
  </required_header>
  <id_info>
    <org_study_id>2017-01677</org_study_id>
    <nct_id>NCT03522025</nct_id>
  </id_info>
  <brief_title>GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs</brief_title>
  <official_title>A Prospective, Multicenter, Randomised Study to Evaluate the Fixation of Cemented and Cementless Design of GMK-UNI Anatomical Knee Prosthesis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Unicompartmental knee arthroplasty (UKA) is the principal surgical alternative to the total&#xD;
      knee arthroplasty (TKA) in patients with end-stage unicompartmental tibiofemoral&#xD;
      osteoarthritis (OA) of the knee. The current comparative randomized study aims to evaluate&#xD;
      the fixation of cemented and cementless designs of GMK-UNI unicompartmental knee prosthesis&#xD;
      over a 5-year time period.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Primary objective is to compare the quality of fixation of cemented and cementless&#xD;
      designs of GMK-UNI unicompartmental knee replacement at 2 years of follow-up.&#xD;
&#xD;
      The Secondary objectives include the evaluation of the patient improvement (subjective and&#xD;
      objective) using the new Knee Society Score (KSS); the patient's anterior pain following UKA&#xD;
      and any eventual patella-femoral disorder; Implant survival rate using the Kaplan Meier&#xD;
      analysis; Post-op radiological findings and Adverse Events.&#xD;
&#xD;
      The Primary outcome aims to compare the occurrence of radiolucency's lines (both partial and&#xD;
      complete) between the two study groups. Secondary outcomes include New KSS, OKS, Kaplan Meier&#xD;
      analysis and stability and fixation of UNI prosthesis.&#xD;
&#xD;
      All patients who meet the inclusion criteria to take part in the current clinical study will&#xD;
      be invited to participate before the surgery.&#xD;
&#xD;
      Subjects will be randomized during the screening; half of them will receive the cemented&#xD;
      GMK-UNI anatomical UKA and the other half the cementless GMK-UNI anatomical UKA.&#xD;
&#xD;
      Clinical data will be recorded on CRF at those time-points:&#xD;
&#xD;
        -  Before the surgery&#xD;
&#xD;
        -  During the surgery&#xD;
&#xD;
        -  After the surgery at 3 months, 1, 2, 3 and 5 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2018</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparing the occurrence of radiolucency's lines</measure>
    <time_frame>5 yrs</time_frame>
    <description>Compare occurrence of radiolucency's lines (both partial and complete)between the two study groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior Knee Pian Scale (Kujala score)</measure>
    <time_frame>pre-op; 3months;1,2,3,5 yrs</time_frame>
    <description>It's a 13-item knee specific self-report questionnaire. It documents response to 6 activities associated with anterior knee pain as well as symptoms such as limp, inability to weight bear through the affected limp, swelling...). It asks about duration of symptoms and limbs affected. Max score is 100 and lower scores indicate greater pain/disability. Scoring is hierarchical using various types of categorisation including &quot;no difficulty-unable &quot; and &quot;no pain-severe pain&quot;. It is easy to understand and takes few minutes to complete.It has a good test-retest reliability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survival rate using Kaplan Meier analysis</measure>
    <time_frame>5 yrs</time_frame>
    <description>Implant survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recording of adverse events</measure>
    <time_frame>Throughout the study</time_frame>
    <description>Any complication occurred during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Knee Score</measure>
    <time_frame>Pre-op;3month;1,2,3,5yrs</time_frame>
    <description>The Oxford Knee Score (OKS) is a 12-item patient-reported PRO specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty).Each question is scored from 1 to 5, with 1 representing best outcome/least symptoms. Scores from each question are added so the overall score is from 12 to 60 (12 being the best outcome). The overall score for the OKS is acquired by simply summing the scores received for individual questions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New Knee Society Score</measure>
    <time_frame>Pre-op:3months;1,2,3,5 yrs</time_frame>
    <description>The new KSS System is a validated and responsive method for assessing objective and subjective outcomes after total and partial knee arthroplasty.It includes versions to be admninstered pre-op and post-op.It has an initial assessment of demographic deatils. The objective knee score includes VAS score of pain walking on level ground and on stairs or inclines, as well as ROM, an assessment of alignment, ligament stability along with deductions for flexion contracture or extensor lag. Pts then record their satisfaction, functional activities and expectations. It consists of 4 subscales: 1) objective knee score (7 items;100 points); 2) Satisfaction Score (5 items; 40 points);3) Expectation Score (3 items; 15 points); 4) Functional Activity Score (19 items; 100 points)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability and fixation of unicompartmental prosthesis</measure>
    <time_frame>5 yrs</time_frame>
    <description>To evaluate the stability and fixation of the prosthesis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>GMK-UNI cemented fixation prosthesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Unicompartmental Knee Arthroplasty (UKA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GMK-UNI cementless fixation prosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unicompartmental Knee Arthroplasty (UKA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Unicompartmental Knee Arthroplasty (UKA)</intervention_name>
    <description>Unicompartmental Knee Arthroplasty (UKA) is a less invasive treatment option compared to Total Knee Arthroplasty (TKA) for patients with primary anteromedial knee osteoarthritis.</description>
    <arm_group_label>GMK-UNI cemented fixation prosthesis</arm_group_label>
    <arm_group_label>GMK-UNI cementless fixation prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients with end-stage unicompartmental tibiofemoral osteoarthritis (OA) of the knee&#xD;
             that meet the indications for use according to Medacta implants included in this study&#xD;
             (on-label use);&#xD;
&#xD;
          -  Those suffering from unilateral osteoarthritis or osteonecrosis of the medial&#xD;
             compartment;&#xD;
&#xD;
          -  Frontal deformity &lt; 10° (evaluated on weight-bearing long-axis x-rays);&#xD;
&#xD;
          -  Flexion contracture &lt; 10°;&#xD;
&#xD;
          -  Intact ligaments;&#xD;
&#xD;
          -  Patients who are willing and able to provide written informed consent for&#xD;
             participation in the study. Written informed consent must be obtained prior to the&#xD;
             patient's surgery;&#xD;
&#xD;
          -  Patient's age over 18 years old;&#xD;
&#xD;
          -  Patient with BMI &lt; 40 kg/m2;&#xD;
&#xD;
          -  Patients must be willing to comply with the pre and post-operative evaluation&#xD;
             schedule.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients with one or more medical conditions identified as a contraindication defined&#xD;
             by the labelling on any Medacta implants used in this study;&#xD;
&#xD;
          -  Any patient who cannot or will not provide informed consent for participation in the&#xD;
             study;&#xD;
&#xD;
          -  Patients who need to undergo lateral unicompartmental knee arthroplasty;&#xD;
&#xD;
          -  Patients who need a revision surgery;&#xD;
&#xD;
          -  Patients who need a patella-femoral joint prosthesis;&#xD;
&#xD;
          -  Patients who had previously undergone high tibial osteotomy or ACL reconstruction;&#xD;
&#xD;
          -  Patients with BMI ≥ 40 kg/m2;&#xD;
&#xD;
          -  Patients unable to understand and take action;&#xD;
&#xD;
          -  Any case not described in the inclusion criteria;&#xD;
&#xD;
          -  Patients aged under 18 years;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dario Bergadano</last_name>
    <phone>00 41 91 690 60 60</phone>
    <email>bergadano@medacta.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Saint Vincent de Paul</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel MARCHETTI</last_name>
      <phone>04 74 43 60 60</phone>
      <email>emmanuelmarchetti@yahoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Mail</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cedric BOUQUET</last_name>
      <phone>05 46 00 43 34</phone>
      <email>docteurbouquet@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Orthéo, Espace Fauriel</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François CHALENCON</last_name>
      <phone>04 77 42 09 82</phone>
      <email>fchalencon@ortheo.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHP Saint-Grégoire</name>
      <address>
        <city>Saint-Grégoire</city>
        <zip>35760</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvan ACQUITTER</last_name>
      <phone>02 23 25 30 75</phone>
      <email>acquitter-y@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Näder Helmy</name>
      <address>
        <city>Solothurn</city>
        <zip>4500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Näder Helmy</last_name>
      <phone>0041 032 627 31 21</phone>
      <email>Naeder.Helmy@spital.so.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2018</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

